|
|
Article: Acologix Presents Preclinical Data on Bone Formation and Maturation Stimulated by AC-100 at the European Orthopedic Research Society Meeting.
- Article from:
- PR Newswire
- Article date:
- June 9, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HAYWARD, Calif., June 8 /PRNewswire/ -- Acologix, Inc., a privately-held biopharmaceutical company, announced today that two preclinical studies demonstrated that AC-100, its novel synthetic peptide derived from an endogenous human protein produced by bone and dental cells, promoted bone formation and maturation in animal models. The data was presented as an oral presentation at the 16th Annual Meeting of the European Orthopedic Research Society in Bologna, Italy.
In a canine tooth extraction model for bone regeneration, extraction sockets were filled with either collagen sponge containing AC-100 at two different doses, or collagen sponge soaked in saline ...